Aurobindo Pharma Share Price
1655.60+18.30 (+1.12%)
+59.98% past 1 Year
News
Aurobindo Pharma sees rumors of promoter-linked block deal activity today
Equity
AUROPHARMA
Aurobindo Pharma sees market buzz on possible promoter-related block deal
Equity
AUROPHARMA
Aurobindo Pharma creates new wholly owned unit Avogent Lifesciences Private Limited
Equity
AUROPHARMA
Aurobindo Pharma gains as Lannett launches generic Advair Diskus in US market
Equity
AUROPHARMA
Aurobindo Pharma unit launches first generic inhalation product in US market
Equity
AUROPHARMA
Aurobindo Pharma unit gets US FDA EIR, inspection closed with issues
Equity
AUROPHARMA
Aurobindo Pharma to hold investor and analyst meet on September 1
Equity
AUROPHARMA
Aurobindo Pharma subsidiary Lannett faces four US FDA compliance issues
Equity
AUROPHARMA
Aurobindo Pharma subsidiary Auro Peptides completes recent US FDA facility inspection
Equity
AUROPHARMA
Aurobindo Pharma unit receives US FDA warning letter on Eugia facility
Equity
AUROPHARMA
Citi maintains sell on Aurobindo Pharma with Rs 1,260 target
Equity
AUROPHARMA
Clsa Maintains Hold On Aurobindo Pharma With Rs 1,600 Target
Equity
AUROPHARMA
Bernstein keeps Aurobindo Pharma at Market Perform after steady Q1 growth
Equity
AUROPHARMA
Aurobindo Pharma Maintains Growth Guidance After Strong First Quarter Performance
Equity
AUROPHARMA
Bofa Securities maintains Buy on Aurobindo Pharma, targets Rs 1,800
Equity
AUROPHARMA
HSBC keeps Buy on Aurobindo Pharma, sees growth from Europe and new launches
Equity
AUROPHARMA
Aurobindo Pharma projects strong FY27 revenue ramp-up for Eugia unit
Equity
AUROPHARMA
Aurobindo Pharma to consolidate Eugia entities into Eugia Pharma Specialities
Equity
AUROPHARMA
Aurobindo Pharma reports strong Q1 EBITDA growth and margin expansion
Equity
AUROPHARMA
Aurobindo Pharma posts strong yoy revenue growth in Q1 FY27 results
Equity
AUROPHARMA